FXYD6P3

associated omics data
Gene

Q-omics provides the consensus-scored FXYD6P3 profile across patient tissues and cancer cell-line models. FXYD6P3 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, FXYD6P3 RNA expression shows 5,718 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight BLCA, and STAD as cancer lineages where FXYD6P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes FXYD6P3 survival associations across molecular data types. FXYD6P3 RNA expression shows survival associations in the most cancer types (9), followed by mutation status (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
FXYD6P3 data typeSurvival analysisLineage consensusLineage of highest sampling consensus
RNAKaplan–Meier9BLCA (99)view →
MutationKaplan–Meier2COAD (24)view →
This table ranks reproducible FXYD6P3 RNA expression–survival associations across cancer types. High FXYD6P3 expression shows unfavorable associations in BLCA, PAAD, BRCA, LUAD and LIHC, but favorable associations in ESCA. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for FXYD6P3 RNA expression.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
BLCADFSTertileAll0.2320.639<.00199view →
PAADOSTertileAll0.1120.613<.00172view →
BRCADFSTertileIII,IV0.1110.497.00254view →
LUADOSTertileII,III,IV0.1030.682<.00136view →
LIHCDFSTertileAll0.1520.545.01227view →
ESCADFSTertileIII,IV0.6350.364.02918view →
Pink = unfavorable, green = favorable. all 9 lineages →

FXYD6P3-BLCA (DFS)

Kaplan–Meier survival curve for FXYD6P3 RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with FXYD6P3 in patient tissues and cancer cell lines. In patient samples, FXYD6P3 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
Associated data typeStrength (# associated data)Lineage of highest associated data
RNA
Function (RNA)5,718STAD (5201)view →
RNA4,139COAD (1950)view →
Mutation
RNA62UCEC (35)view →